EZH2 and neoplasm: The function of EZH2 in different cell types within the TME has shown that patients may still be able to mount an anti-tumour response due to the effect on antigen presentation and T cell function; however, other cell populations including TAMs are skewed to pro-tumour phenotype as a result of EZH2 inhibition.